Clinical Trial Update: Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating neoadjuvant bevacizumab, capecitabine, and radiation with or without oxaliplatin for locally advanced rectal cancer; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-07-10